JAYME BLESSINGER: Open Payments
NPI 1184029019 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $33 |
| Lundbeck LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $13 |
Products named: REXULTI, GEMTESA, NEXLETOL, MYFEMBREE, KISUNLA, ZERBAXA, MOUNJARO, JARDIANCE.
Industry payments across IN — which companies pay providers there.
